IL6 and breast carcinoma: To further elucidate the role of activated macrophages in promotion of angiogenic potential of breast cancer cells, 4T1 cells were treated with either CM of activated RAW264.7 or CM of activated RAW264.7 neutralized with IL-6 antibody.